This isn't about whistleblowers [BE/BA News]

posted by DavidManteigas – Portugal, 2017-05-25 14:37 (3306 d 00:43 ago) – Posting: # 17414
Views: 7,093

Hi Dr. Dan,

Not necessarily. If they don't report according to the guideline they could always be subject to an inspection and than have a "double finding". Also, regulators have access in their data to what is the "average" reporting of this kind of troubles, so they can even made inspections on a "risk-based" approach and under-reporting of findings would be one of the "triggers" for inspection.

Regards,
David

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
99 visitors (0 registered, 99 guests [including 24 identified bots]).
Forum time: 15:20 CEST (Europe/Vienna)

To propose that poor design can be corrected by subtle analysis techniques
is contrary to good scientific thinking.    Stuart J. Pocock

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5